SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M.M.N. Bieńkiewicz, W.R. Young, C.M. Craig, Balls to the wall: How acoustic information from a ball in motion guides interceptive movement in people with Parkinson’s disease, Neuroscience, 2014, 275, 508

    CrossRef

  2. 2
    Ashley McGill, Sara Houston, Raymond Y.W. Lee, Dance for Parkinson's: A new framework for research on its physical, mental, emotional, and social benefits, Complementary Therapies in Medicine, 2014, 22, 3, 426

    CrossRef

  3. 3
    Nur-Ezan Mohamed, David R. Howlett, Lu Ma, Paul T. Francis, Dag Aarsland, Clive G. Ballard, Ian G. McKeith, Christopher P. Chen, Mitchell K. P. Lai, Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias, Journal of Neural Transmission, 2014, 121, 1, 71

    CrossRef

  4. 4
    Janine A. Simons, Urban M. Fietzek, Annika Waldmann, Tobias Warnecke, Tibor Schuster, Andrés O. Ceballos-Baumann, Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 9, 992

    CrossRef

  5. 5
    Jennifer L. Whitwell, Christopher G. Schwarz, Robert I. Reid, Kejal Kantarci, Clifford R. Jack, Keith A. Josephs, Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes, Parkinsonism & Related Disorders, 2014, 20, 5, 493

    CrossRef

  6. 6
    Tara M. Madhyastha, Mary K. Askren, Peter Boord, Thomas J. Grabowski, Dynamic Connectivity at Rest Predicts Attention Task Performance, Brain Connectivity, 2014, 140819114316003

    CrossRef

  7. 7
    Deborah Aitken, Sharon L. Naismith, Zoe Terpening, Simon J.G. Lewis, Dysfunctional sleep beliefs in Parkinson’s disease: Relationships with subjective and objective sleep, Journal of Clinical Neuroscience, 2014, 21, 8, 1359

    CrossRef

  8. 8
    Beatriz Alvarez-Castelao, Ana Gorostidi, Javier Ruíz-Martínez, Adolfo López de Munain, José G. Castaño, Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy Controls, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  9. 9
    F. Spagnolo, M.A. Volonté, M. Fichera, R. Chieffo, E. Houdayer, M. Bianco, E. Coppi, A. Nuara, L. Straffi, G. Di Maggio, L. Ferrari, D. Dalla Libera, S. Velikova, G. Comi, A. Zangen, L. Leocani, Excitatory Deep Repetitive Transcranial Magnetic Stimulation With H-coil as Add-on Treatment of Motor Symptoms in Parkinson's Disease: An Open Label, Pilot Study, Brain Stimulation, 2014, 7, 2, 297

    CrossRef

  10. 10
    Nicolaas I. Bohnen, Kirk A. Frey, Stephanie Studenski, Vikas Kotagal, Robert A. Koeppe, Gregory M. Constantine, Peter J.H. Scott, Roger L. Albin, Martijn L.T.M. Müller, Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography study, Movement Disorders, 2014, 29, 9
  11. 11
    M. Rodríguez-Violante, A. Camacho-Ordoñez, A. Cervantes-Arriaga, P. González-Latapí, S. Velázquez-Osuna, Factores asociados a la calidad de vida de sujetos con enfermedad de Parkinson y a la carga en el cuidador, Neurología, 2014,

    CrossRef

  12. 12
    Tatjana Gazibara, Tatjana Pekmezovic, Darija Kisic Tepavcevic, Aleksandra Tomic, Iva Stankovic, Vladimir S Kostic, Marina Svetel, Fall frequency and risk factors in patients with Parkinson's disease in Belgrade, Serbia: A cross-sectional study, Geriatrics & Gerontology International, 2014, 14, 3
  13. 13
    Christopher G. Goetz, Glenn T. Stebbins, Lu Wang, Nancy R. LaPelle, Sheng Luo, Barbara C. Tilley, IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS, Movement Disorders Clinical Practice, 2014, 1, 2
  14. 14
    Aner Weiss, Talia Herman, Nir Giladi, Jeffrey M. Hausdorff, New evidence for gait abnormalities among Parkinson’s disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days, Journal of Neural Transmission, 2014,

    CrossRef

  15. 15
    Mariana P Santos, Angélica C Ovando, Bruna A Silva, Samanta RCB Fontana, Caroline C do Espírito Santo, Jocemar Ilha, Alessandra Swarowsky, Parkinson Activity Scale: Cross-cultural adaptation and reliability of the Brazilian version, Geriatrics & Gerontology International, 2014, 14, 3
  16. 16
    Prashanth Reddy, Pablo Martinez-Martin, Richard G Brown, Kallol Chaudhuri, Jean-Pierre Lin, Richard Selway, Ian Forgacs, Keyoumars Ashkan, Michael Samuel, Perceptions of symptoms and expectations of advanced therapy for Parkinson’s disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson’s disease (PRO-APD), Health and Quality of Life Outcomes, 2014, 12, 1, 11

    CrossRef

  17. 17
    Wafa Regragui, Lamiae Lachhab, Rachid Razine, Leila Raissouni, Khaoula Rasmouni, Fatima Imounan, El hachmia Benhaddou, Redouane Abouqal, Ali Benomar, Mohamed Yahyaoui, Profile of idiopathic parkinson’s disease in Moroccan patients, International Archives of Medicine, 2014, 7, 1, 10

    CrossRef

  18. 18
    P. Martínez-Martín, C. Rodríguez-Blázquez, M. J. Forjaz, M. Álvarez-Sánchez, T. Arakaki, A. Bergareche-Yarza, A. Chade, N. Garretto, O. Gershanik, M. M. Kurtis, J. C. Martínez-Castrillo, A. Mendoza-Rodríguez, H. P. Moore, M. Rodríguez-Violante, C. Singer, B. C. Tilley, J. Huang, G. T. Stebbins, C. G. Goetz, Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients , European Journal of Neurology, 2014, 21, 3
  19. 19
    Wooyoung Jang, Jinse Park, Kyung Jin Shin, Joong-Seok Kim, Ji Sun Kim, Jinyoung Youn, Jin Whan Cho, Eungseok Oh, Jin Young Ahn, Ki-Wook Oh, Hee-Tae Kim, Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease, Journal of the Neurological Sciences, 2014, 337, 1-2, 47

    CrossRef

  20. 20
    James M. Shine, Glenda M. Halliday, Moran Gilat, Elie Matar, Samuel J. Bolitho, Maria Carlos, Sharon L. Naismith, Simon J.G. Lewis, The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease, Human Brain Mapping, 2014, 35, 5
  21. 21
    Eva Pirogovsky, Dawn M. Schiehser, Irene Litvan, Kristalyn M. Obtera, Mathes M. Burke, Stephanie L. Lessig, David D. Song, Lin Liu, J. Vincent Filoteo, The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment, Parkinsonism & Related Disorders, 2014, 20, 6, 627

    CrossRef

  22. 22
    E. Apartis, C.-P. Jedynak, Tremori, EMC - Neurologia, 2014, 14, 1, 1

    CrossRef

  23. 23
    E. Matar, J.M. Shine, S.L. Naismith, S.J.G. Lewis, Virtual reality walking and dopamine: Opening new doorways to understanding freezing of gait in Parkinson's disease, Journal of the Neurological Sciences, 2014, 344, 1-2, 182

    CrossRef

  24. 24
    J. P. M. van der Vegt, O. J. Hulme, S. Zittel, K. H. Madsen, M. M. Weiss, C. Buhmann, B. R. Bloem, A. Munchau, H. R. Siebner, Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease, Brain, 2013, 136, 4, 1192

    CrossRef

  25. 25
    M. Kasten, J. Hagenah, J. Graf, A. Lorwin, E.-J. Vollstedt, E. Peters, A. Katalinic, H. Raspe, C. Klein, Cohort Profile: A population-based cohort to study non-motor symptoms in parkinsonism (EPIPARK), International Journal of Epidemiology, 2013, 42, 1, 128

    CrossRef

  26. 26
    Erin R. Foster, Laura Golden, Ryan P. Duncan, Gammon M. Earhart, Community-Based Argentine Tango Dance Program Is Associated With Increased Activity Participation Among Individuals With Parkinson's Disease, Archives of Physical Medicine and Rehabilitation, 2013, 94, 2, 240

    CrossRef

  27. 27
    W. P. Teo, J. P. Rodrigues, F. L. Mastaglia, G. W. Thickbroom, Comparing kinematic changes between a finger-tapping task and unconstrained finger flexion–extension task in patients with Parkinson’s disease, Experimental Brain Research, 2013, 227, 3, 323

    CrossRef

  28. 28
    Jennifer G. Goldman, Reena A. Ghode, Bichun Ouyang, Bryan Bernard, Christopher G. Goetz, Glenn T. Stebbins, Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 9, 806

    CrossRef

  29. 29
    Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Mario Alvarez-Sanchez, Tomoko Arakaki, Alberto Bergareche-Yarza, Anabel Chade, Nelida Garretto, Oscar Gershanik, Monica M. Kurtis, Juan Carlos Martinez-Castrillo, Amelia Mendoza-Rodriguez, Henry P. Moore, Mayela Rodriguez-Violante, Carlos Singer, Barbara C. Tilley, Jing Huang, Glenn T. Stebbins, Christopher G. Goetz, Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), Journal of Neurology, 2013, 260, 1, 228

    CrossRef

  30. 30
    J. M. Shine, E. Matar, P. B. Ward, S. J. Bolitho, M. Gilat, M. Pearson, S. L. Naismith, S. J. G. Lewis, Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease, Brain, 2013, 136, 4, 1204

    CrossRef

  31. 31
    Vikas Kotagal, Roger L. Albin, Martijn L. T. M. Müller, Robert A. Koeppe, Kirk A. Frey, Nicolaas I. Bohnen, Gender differences in cholinergic and dopaminergic deficits in Parkinson disease, Journal of Neural Transmission, 2013, 120, 10, 1421

    CrossRef

  32. 32
    Pablo Martinez-Martin, Instruments for holistic assessment of Parkinson’s disease, Journal of Neural Transmission, 2013, 120, 4, 559

    CrossRef

  33. 33
    Brook Galna, Sue Lord, Lynn Rochester, Is gait variability reliable in older adults and Parkinson's disease? Towards an optimal testing protocol, Gait & Posture, 2013, 37, 4, 580

    CrossRef

  34. 34
    Sarah Williams, Allison Gregory, Penelope Hogarth, Susan J. Hayflick, Melanie B. Gillingham, Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration, Molecular Genetics and Metabolism, 2013, 110, 3, 336

    CrossRef

  35. 35
    Jakub M. Antczak, Maria J. Rakowicz, Marta Banach, Mirosława Derejko, Jakub Sienkiewicz, Urszula Zalewska, Małgorzata Więcławska, Tomasz Jakubczyk, Wojciech Jernajczyk, Negative influence of L-dopa on subjectively assessed sleep but not on nocturnal polysomnography in Parkinson's disease, Pharmacological Reports, 2013, 65, 3, 614

    CrossRef

  36. 36
    J. L. Whitwell, J. R. Duffy, E. A. Strand, M. M. Machulda, M. L. Senjem, J. L. Gunter, K. Kantarci, S. D. Eggers, C. R. Jack, K. A. Josephs, Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy, European Journal of Neurology, 2013, 20, 4
  37. 37
    Ramón Fernández de Bobadilla, Javier Pagonabarraga, Saül Martínez-Horta, Berta Pascual-Sedano, Antonia Campolongo, Jaime Kulisevsky, Parkinson's disease-cognitive rating scale: Psychometrics for mild cognitive impairment, Movement Disorders, 2013, 28, 10
  38. 38
    Judy K. Qiang, Yvette C. Wong, Andrew Siderowf, Howard I. Hurtig, Sharon X. Xie, Virginia M.-Y. Lee, John Q. Trojanowski, Dora Yearout, James B. Leverenz, Thomas J. Montine, Matt Stern, Susan Mendick, Danna Jennings, Cyrus Zabetian, Ken Marek, Alice S. Chen-Plotkin, Plasma apolipoprotein A1 as a biomarker for Parkinson disease, Annals of Neurology, 2013, 74, 1
  39. 39
    Eva Pirogovsky, Mercedes Martinez-Hannon, Dawn M. Schiehser, Stephanie L. Lessig, David D. Song, Irene Litvan, J. Vincent Filoteo, Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson’s disease, Journal of Clinical and Experimental Neuropsychology, 2013, 35, 9, 926

    CrossRef

  40. 40
    M. L. T. M. Muller, R. L. Albin, V. Kotagal, R. A. Koeppe, P. J. H. Scott, K. A. Frey, N. I. Bohnen, Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease, Brain, 2013, 136, 11, 3282

    CrossRef

  41. 41
    J.M. Shine, S.L. Naismith, S.J.G. Lewis, The differential yet concurrent contributions of motor, cognitive and affective disturbance to freezing of gait in Parkinson's disease, Clinical Neurology and Neurosurgery, 2013, 115, 5, 542

    CrossRef

  42. 42
    Elie Matar, James M. Shine, Sharon L. Naismith, Simon J.G. Lewis, Using virtual reality to explore the role of conflict resolution and environmental salience in Freezing of Gait in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 11, 937

    CrossRef

  43. 43
    Tatjana Gazibara, Iva Stankovic, Aleksandra Tomic, Marina Svetel, Darija Kisic Tepavcevic, Vladimir S. Kostic, Tatjana Pekmezovic, Validation and cross-cultural adaptation of the Self-Assessment Disability Scale in patients with Parkinson’s disease in Serbia, Journal of Neurology, 2013, 260, 8, 1970

    CrossRef

  44. 44
    Angelo Antonini, Giovanni Abbruzzese, Luigi Ferini-Strambi, Barbara Tilley, Jing Huang, Glenn T. Stebbins, Christopher G. Goetz, Paolo Barone, Monica Bandettini di Poggio, Giovanni Fabbrini, Flavio Di Stasio, Michele Tinazzi, Tommaso Bovi, Silvia Ramat, Sara Meoni, Gianni Pezzoli, Margherita Canesi, Paolo Martinelli, Cesa Lorella Maria Scaglione, Aroldo Rossi, Nicola Tambasco, Gabriella Santangelo, Marina Picillo, Letterio Morgante, Francesca Morgante, Rocco Quatrale, MariaChiara Sensi, Manuela Pilleri, Roberta Biundo, Giampietro Nordera, Antonella Caria, Claudio Pacchetti, Roberta Zangaglia, Leonardo Lopiano, Maurizio Zibetti, Mario Zappia, Alessandra Nicoletti, Aldo Quattrone, Maria Salsone, Gianni Cossu, Daniela Murgia, Alberto Albanese, Francesca Del Sorbo, Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale, Neurological Sciences, 2013, 34, 5, 683

    CrossRef

  45. 45
    Martijn L.T.M. Müller, Kirk A. Frey, Myria Petrou, Vikas Kotagal, Robert A. Koeppe, Roger L. Albin, Nicolaas I. Bohnen, β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia, Movement Disorders, 2013, 28, 3
  46. 46
    Joseph Jankovic, Raja Mehanna, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  47. 47
    Pouya Movahed, M Mitra, K Chaudhuri, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  48. 48
    Joseph Jankovic, Raja Mehanna, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  49. 49
    Pouya Movahed, M. Tanya Mitra, K. Ray Chaudhuri, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  50. 50
    Ryan P. Duncan, Abigail L. Leddy, James T. Cavanaugh, Leland E. Dibble, Terry D. Ellis, Matthew P. Ford, K. Bo Foreman, Gammon M. Earhart, Accuracy of Fall Prediction in Parkinson Disease: Six-Month and 12-Month Prospective Analyses, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  51. 51
    J.M. Shine, S.T. Moore, S.J. Bolitho, T.R. Morris, V. Dilda, S.L. Naismith, S.J.G. Lewis, Assessing the utility of Freezing of Gait Questionnaires in Parkinson’s Disease, Parkinsonism & Related Disorders, 2012, 18, 1, 25

    CrossRef

  52. 52
    Bozena Kostek, Katarzyna Kaszuba, Pawel Zwan, Piotr Robowski, Jaroslaw Slawek, Automatic assessment of the motor state of the Parkinson's disease patient--a case study, Diagnostic Pathology, 2012, 7, 1, 18

    CrossRef

  53. 53
    Manfred Gerlach, Walter Maetzler, Karl Broich, Harald Hampel, Lucas Rems, Torsten Reum, Peter Riederer, Albrecht Stöffler, Johannes Streffer, Daniela Berg, Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics, Journal of Neural Transmission, 2012, 119, 1, 39

    CrossRef

  54. 54
    Christopher G. Goetz, Glenn T. Stebbins, Barbara C. Tilley, Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores, Movement Disorders, 2012, 27, 10
  55. 55
    Francesca Del Sorbo, Alberto Albanese, Clinical management of pain and fatigue in Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S233

    CrossRef

  56. 56
    Maja Relja, Clinical rating scales, Parkinsonism & Related Disorders, 2012, 18, S229

    CrossRef

  57. 57
    Martina A. Maggioni, Arsenio Veicsteinas, Susanna Rampichini, Emiliano Cè, Raffaello Nemni, Giulio Riboldazzi, Giampiero Merati, Energy cost of spontaneous walking in Parkinson’s disease patients, Neurological Sciences, 2012, 33, 4, 779

    CrossRef

  58. 58
    Thomas O. Mera, Dustin A. Heldman, Alberto J. Espay, Megan Payne, Joseph P. Giuffrida, Feasibility of home-based automated Parkinson's disease motor assessment, Journal of Neuroscience Methods, 2012, 203, 1, 152

    CrossRef

  59. 59
    Nicolaas I Bohnen, Martijn L T M Müller, Vikas Kotagal, Robert A Koeppe, Michael R Kilbourn, Sid Gilman, Roger L Albin, Kirk A Frey, Heterogeneity of cholinergic denervation in Parkinson's disease without dementia, Journal of Cerebral Blood Flow & Metabolism, 2012, 32, 8, 1609

    CrossRef

  60. 60
    Li-Ann Leow, Andrea M. Loftus, Geoffrey R. Hammond, Impaired savings despite intact initial learning of motor adaptation in Parkinson’s disease, Experimental Brain Research, 2012, 218, 2, 295

    CrossRef

  61. 61
    K. A. Josephs, S. D. Z. Eggers, C. R. Jack, J. L. Whitwell, Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid, European Journal of Neurology, 2012, 19, 11
  62. 62
    Elizabeth A. Coon, Jennifer L. Whitwell, Clifford R. Jack, Keith A. Josephs, Primary lateral sclerosis as progressive supranuclear palsy: Diagnosis by diffusion tensor imaging, Movement Disorders, 2012, 27, 7
  63. 63
    Meg E Morris, Clarissa Martin, Jennifer L McGinley, Frances E Huxham, Hylton B Menz, Nicholas F Taylor, Mary Danoudis, Jennifer J Watts, Sze-Ee Soh, Andrew H Evans, Malcolm Horne, Peter Kempster, Protocol for a home-based integrated physical therapy program to reduce falls and improve mobility in people with Parkinson’s disease, BMC Neurology, 2012, 12, 1, 54

    CrossRef

  64. 64
    Ryan P. Duncan, Gammon M. Earhart, Should One Measure Balance or Gait to Best Predict Falls among People with Parkinson Disease?, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  65. 65
    Sydney E. Seidel, Barbara C. Tilley, Peng Huang, Yuko Y. Palesch, Kenneth J. Bergmann, Christopher G. Goetz, Christopher J. Swearingen, Subject-investigator reproducibility of the Unified Parkinson’s Disease Rating Scale, Parkinsonism & Related Disorders, 2012, 18, 3, 230

    CrossRef

  66. 66
    Vikas Kotagal, Roger L. Albin, Martijn L. T. M. Müller, Robert A. Koeppe, Ronald D. Chervin, Kirk A. Frey, Nicolaas I. Bohnen, Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease, Annals of Neurology, 2012, 71, 4
  67. 67
    Jonathan R. Evans, Sarah L. Mason, Roger A. Barker, Functional Neural Transplantation III - Primary and Stem Cell Therapies for Brain Repair, Part I, 2012,

    CrossRef

  68. 68
    Zinovia Kefalopoulou, Iciar Aviles-Olmos, Thomas Foltynie, Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  69. 69
    Jonathan R Evans, Roger A Barker, Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease, Expert Opinion on Pharmacotherapy, 2011, 12, 8, 1249

    CrossRef

  70. 70
    Keith A. Josephs, Jennifer L. Whitwell, Scott D. Eggers, Matthew L. Senjem, Clifford R. Jack, Gray matter correlates of behavioral severity in progressive supranuclear palsy, Movement Disorders, 2011, 26, 3
  71. 71
    Thomas Mera, Jerrold L. Vitek, Jay L. Alberts, Joseph P. Giuffrida, Kinematic optimization of deep brain stimulation across multiple motor symptoms in Parkinson's disease, Journal of Neuroscience Methods, 2011, 198, 2, 280

    CrossRef

  72. 72
    C. Warren Olanow, Kathryn B. Wunderle, Karl Kieburtz, Milestones in movement disorders clinical trials: Advances and landmark studies, Movement Disorders, 2011, 26, 6
  73. 73
    Claudia Trenkwalder, Ralf Kohnen, Birgit Högl, Vinod Metta, Friederike Sixel-Döring, Birgit Frauscher, Julia Hülsmann, Pablo Martinez-Martin, Kallol Ray Chaudhuri, Parkinson's disease sleep scale—validation of the revised version PDSS-2, Movement Disorders, 2011, 26, 4
  74. 74
    K. Ray Chaudhuri, Per Odin, Angelo Antonini, Pablo Martinez-Martin, Parkinson’s disease: The non-motor issues, Parkinsonism & Related Disorders, 2011, 17, 10, 717

    CrossRef

  75. 75
    Jakub Antczak, Maria Rakowicz, Marta Banach, Mirosława Derejko, Jakub Sienkiewicz, Urszula Zalewska, Małgorzata Więcławska, Wojciech Jernajczyk, The Influence of Repetitive Transcranial Magnetic Stimulation on Sleep in Parkinson’s Disease, Biocybernetics and Biomedical Engineering, 2011, 31, 3, 35

    CrossRef

  76. 76
    Klaus Seppi, Daniel Weintraub, Miguel Coelho, Santiago Perez-Lloret, Susan H. Fox, Regina Katzenschlager, Eva-Maria Hametner, Werner Poewe, Olivier Rascol, Christopher G. Goetz, Cristina Sampaio, The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease, Movement Disorders, 2011, 26, S3
  77. 77
    David J Daley, Katherine HO Deane, Richard J Gray, Paul F Worth, Allan B Clark, Kanagasabesan Sabanathan, Michael Pfeil, Phyo K Myint, The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial, Trials, 2011, 12, 1, 251

    CrossRef

  78. 78
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  79. 79
    Joseph Giuffrida, Edward Rapp, Healthcare Sensor Networks, 2011,

    CrossRef

  80. 80
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  81. 81
    Pablo Martinez-Martin, Composite rating scales, Journal of the Neurological Sciences, 2010, 289, 1-2, 7

    CrossRef

  82. 82
    J. Seco Calvo, I. Gago Fernández, Eficacia de un programa intensivo y continuado de fisioterapia para la mejoría clínica en pacientes con enfermedad de Parkinson, Fisioterapia, 2010, 32, 5, 208

    CrossRef

  83. 83
    C.G. Goetz, Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : une nouvelle échelle pour l’évaluation de la maladie de Parkinson, Revue Neurologique, 2010, 166, 1, 1

    CrossRef

  84. 84
    Christopher G. Goetz, New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease, Movement Disorders, 2010, 25, S1
  85. 85
    Stanley Fahn, Parkinson's disease: 10 years of progress, 1997–2007, Movement Disorders, 2010, 25, S1
  86. 86
    Herbert Y Meltzer, Roger Mills, Stephen Revell, Hilde Williams, Ann Johnson, Daun Bahr, Joseph H Friedman, Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis, Neuropsychopharmacology, 2010, 35, 4, 881

    CrossRef

  87. 87
    Margaret Schenkman, Kimberly McFann, Anna E. Barón, PROFILE PD, Journal of Neurologic Physical Therapy, 2010, 34, 4, 182

    CrossRef

  88. 88
    Christopher G. Goetz, Glenn T. Stebbins, Teresa A. Chmura, Stanley Fahn, Werner Poewe, Caroline M. Tanner, Teaching program for the movement disorder society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS), Movement Disorders, 2010, 25, 9
  89. 89
    Janice L. Palmer, Mary A. Coats, Catherine M. Roe, Shelly M. Hanko, Chengjie Xiong, John C. Morris, Unified Parkinson’s Disease Rating Scale-Motor Exam: inter-rater reliability of advanced practice nurse and neurologist assessments, Journal of Advanced Nursing, 2010, 66, 6
  90. 90
    C.G. Goetz, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  91. 91
    P. Martinez-Martin, C. Rodríguez Blázquez, M. João Forjaz, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  92. 92
    C. Warren Olanow, Olivier Rascol, Robert Hauser, Paul D. Feigin, Joseph Jankovic, Anthony Lang, William Langston, Eldad Melamed, Werner Poewe, Fabrizio Stocchi, Eduardo Tolosa, A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease, New England Journal of Medicine, 2009, 361, 13, 1268

    CrossRef

  93. 93
    Gráinne C. O’Keeffe, Andrew W. Michell, Roger A. Barker, Biomarkers in Huntington's and Parkinson's Disease, Annals of the New York Academy of Sciences, 2009, 1180, 1
  94. 94
    Karim Farid, Igor Sibon, Dominique Guehl, Emmanuel Cuny, Pierre Burbaud, Michèle Allard, Brain dopaminergic modulation associated with executive function in Parkinson's disease, Movement Disorders, 2009, 24, 13
  95. 95
    Joseph P. Giuffrida, David E. Riley, Brian N. Maddux, Dustin A. Heldman, Clinically deployable Kinesia™ technology for automated tremor assessment, Movement Disorders, 2009, 24, 5
  96. 96
    Patrick J. Grover, Erlick A.C. Pereira, Alexander L. Green, John-Stuart Brittain, Sarah L.F. Owen, Patrick Schweder, Morten L. Kringelbach, Paul T.G. Davies, Tipu Z. Aziz, Deep brain stimulation for cluster headache, Journal of Clinical Neuroscience, 2009, 16, 7, 861

    CrossRef

  97. 97
    Frandy Susatia, Hubert H. Fernandez, Drug-induced parkinsonism, Current Treatment Options in Neurology, 2009, 11, 3, 162

    CrossRef

  98. 98
    Marian L. Evatt, K. Ray Chaudhuri, Kelvin L. Chou, Ester Cubo, Vanessa Hinson, Katie Kompoliti, Chengwu Yang, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Christopher G. Goetz, Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease, Movement Disorders, 2009, 24, 5
  99. 99
    J.E. Myers, J. Fine, D. Ormond-Brown, J. Fry, A. Thomson, M.L. Thompson, Estimating the prevalence of clinical manganism using a cascaded screening process in a South African manganese smelter, NeuroToxicology, 2009, 30, 6, 934

    CrossRef

  100. 100
    E. Ray Dorsey, Joel P. Thompson, Mark Frasier, Todd Sherer, Brian Fiske, Sean Nicholson, S. Claiborne Johnston, Robert G. Holloway, Hamilton Moses, Funding of Parkinson research from industry and US federal and foundation sources, Movement Disorders, 2009, 24, 5
  101. 101
    Robert G. Hart, Lesly A. Pearce, Bernard M. Ravina, Toby C. Yaltho, John R. Marler, Neuroprotection trials in Parkinson's disease: Systematic review, Movement Disorders, 2009, 24, 5
  102. 102
    Jau-Shin Lou, Physical and Mental Fatigue in Parkinsonʼs Disease, Drugs & Aging, 2009, 26, 3, 195

    CrossRef

  103. 103
    Walter Maetzler, Inga Liepelt, Daniela Berg, Progression of Parkinson's disease in the clinical phase: potential markers, The Lancet Neurology, 2009, 8, 12, 1158

    CrossRef

  104. 104
    Yasin Temel, Veerle Visser-Vandewalle, Roger H.S. Carpenter, Saccadometry: A novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson's disease, Experimental Neurology, 2009, 216, 2, 481

    CrossRef

  105. 105
    Peng Huang, Christopher G. Goetz, Robert F. Woolson, Barbara Tilley, Douglas Kerr, Yuko Palesch, Jordan Elm, Bernard Ravina, Kenneth J. Bergmann, Karl Kieburtz, Using global statistical tests in long-term Parkinson's disease clinical trials, Movement Disorders, 2009, 24, 12
  106. 106
    Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martinez-Martin, Irene H. Richard, Sergio E. Starkstein, Daniel Weintraub, Christina Sampaio, Werner Poewe, Oliver Rascol, Glenn T. Stebbins, Christopher G. Goetz, Anxiety rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2008, 23, 14
  107. 107
    Albert F.G. Leentjens, Kathy Dujardin, Laura Marsh, Pablo Martinez-Martin, Irene H. Richard, Sergio E. Starkstein, Daniel Weintraub, Cristina Sampaio, Werner Poewe, Oliver Rascol, Glenn T. Stebbins, Christopher G. Goetz, Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, 2008, 23, 14
  108. 108
    Charlotte A. Haaxma, Bastiaan R. Bloem, George F. Borm, Martin W.I.M. Horstink, Comparison of a timed motor test battery to the Unified Parkinson's Disease Rating Scale-III in Parkinson's disease, Movement Disorders, 2008, 23, 12
  109. 109
    Karla M Eggert, Jens P Reese, Wolfgang H Oertel, Richard Dodel, Cost Effectiveness of Pharmacotherapies in Early Parkinson’s Disease, CNS Drugs, 2008, 22, 10, 841

    CrossRef

  110. 110
    Travis B. Lewis, David G. Standaert, Design of clinical trials of gene therapy in Parkinson disease, Experimental Neurology, 2008, 209, 1, 41

    CrossRef

  111. 111
    David A Gallagher, Anette Schrag, Impact of Newer Pharmacological Treatments on Quality of Life in Patients with Parkinson???s Disease, CNS Drugs, 2008, 22, 7, 563

    CrossRef

  112. 112
    Alastair J. Martin, Paul S. Larson, Jill L. Ostrem, Philip A. Starr, Interventional Magnetic Resonance Guidance of Deep Brain Stimulator Implantation for Parkinson Disease, Topics in Magnetic Resonance Imaging, 2008, 19, 4, 213

    CrossRef

  113. You have free access to this content113
    Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B. Stern, Richard Dodel, Bruno Dubois, Robert Holloway, Joseph Jankovic, Jaime Kulisevsky, Anthony E. Lang, Andrew Lees, Sue Leurgans, Peter A. LeWitt, David Nyenhuis, C. Warren Olanow, Olivier Rascol, Anette Schrag, Jeanne A. Teresi, Jacobus J. van Hilten, Nancy LaPelle, Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results, Movement Disorders, 2008, 23, 15
  114. 114
    Christopher G. Goetz, Joanne Wuu, Michael P. McDermott, Charles H. Adler, Stanley Fahn, Curt R. Freed, Robert A. Hauser, Warren C. Olanow, Ira Shoulson, P.K. Tandon, Sue Leurgans, Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions, Movement Disorders, 2008, 23, 5
  115. 115
    Peter A. LeWitt, Danette C. Taylor, Protection against Parkinson’s disease progression: Clinical experience, Neurotherapeutics, 2008, 5, 2, 210

    CrossRef

  116. 116
    Jan Raethjen, Kristina Austermann, Karsten Witt, Kirsten E. Zeuner, Frank Papengut, Günther Deuschl, Provocation of Parkinsonian tremor, Movement Disorders, 2008, 23, 7
  117. 117
    Hubert H. Fernandez, Dag Aarsland, Gilles Fénelon, Joseph H. Friedman, Laura Marsh, Alexander I. Tröster, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Christopher G. Goetz, Scales to assess psychosis in Parkinson's disease: Critique and recommendations, Movement Disorders, 2008, 23, 4
  118. 118
    Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Belen Frades-Payo, Specific patient-reported outcome measures for Parkinson’s disease: analysis and applications, Expert Review of Pharmacoeconomics & Outcomes Research, 2008, 8, 4, 401

    CrossRef

  119. 119
    L. Rossi, S. Marceglia, G. Foffani, F. Cogiamanian, F. Tamma, P. Rampini, S. Barbieri, F. Bracchi, A. Priori, Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease, Brain Research Bulletin, 2008, 76, 5, 512

    CrossRef

  120. 120
    Christopher G. Goetz, John G. Nutt, Glenn T. Stebbins, The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile, Movement Disorders, 2008, 23, 16
  121. 121
    Kenn Freddy Pedersen, Jan Petter Larsen, Dag Aarsland, Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease, Parkinsonism & Related Disorders, 2008, 14, 3, 183

    CrossRef

  122. 122
    Birgit Högl, Viola Gschliesser, RLS assessment and sleep questionnaires in practice – Lessons learned from Parkinson’s disease, Sleep Medicine, 2007, 8, S7

    CrossRef

  123. 123
    Kallol Ray Chaudhuri, Pablo Martinez-Martin, Richard G. Brown, Kapil Sethi, Fabrizio Stocchi, Per Odin, William Ondo, Kazuo Abe, Graeme MacPhee, Doug MacMahon, Paolo Barone, Martin Rabey, Alison Forbes, Kieran Breen, Susanne Tluk, Yogini Naidu, Warren Olanow, Adrian J. Williams, Sue Thomas, David Rye, Yoshio Tsuboi, Annette Hand, Anthony H.V. Schapira, The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study, Movement Disorders, 2007, 22, 13
  124. 124
    Christopher G. Goetz, Cristina Sampaio, Assessment of Non-Motor Features of Parkinson's Disease: Scales and Rating Tools,
  125. 125
    Joel S. Perlmutter, Assessment of Parkinson Disease Manifestations, Current Protocols in Neuroscience,
  126. 126
    Karl Kieburtz, Clinical Trial Measures of the Non-Motor Features of Parkinson's Disease,
  127. 127
    Gammon M. Earhart, Michael J. Falvo, Parkinson Disease and Exercise, Comprehensive Physiology,